BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31152789)

  • 1. Nucleocytoplasmic transport defects in neurodegeneration - Cause or consequence?
    Hutten S; Dormann D
    Semin Cell Dev Biol; 2020 Mar; 99():151-162. PubMed ID: 31152789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleocytoplasmic Transport: Regulatory Mechanisms and the Implications in Neurodegeneration.
    Ding B; Sepehrimanesh M
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traffic jam at the nuclear pore: All roads lead to nucleocytoplasmic transport defects in ALS/FTD.
    Fallini C; Khalil B; Smith CL; Rossoll W
    Neurobiol Dis; 2020 Jul; 140():104835. PubMed ID: 32179176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hitchhiker's Guide to Nucleocytoplasmic Trafficking in Neurodegeneration.
    Moore S; Rabichow BE; Sattler R
    Neurochem Res; 2020 Jun; 45(6):1306-1327. PubMed ID: 32086712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lost in Transportation: Nucleocytoplasmic Transport Defects in ALS and Other Neurodegenerative Diseases.
    Kim HJ; Taylor JP
    Neuron; 2017 Oct; 96(2):285-297. PubMed ID: 29024655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear pore complexes - a doorway to neural injury in neurodegeneration.
    Coyne AN; Rothstein JD
    Nat Rev Neurol; 2022 Jun; 18(6):348-362. PubMed ID: 35488039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perturbations in Traffic: Aberrant Nucleocytoplasmic Transport at the Heart of Neurodegeneration.
    Fahrenkrog B; Harel A
    Cells; 2018 Nov; 7(12):. PubMed ID: 30486313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration.
    Ferreira PA
    Cell Mol Life Sci; 2019 Jun; 76(12):2247-2273. PubMed ID: 30742233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA Nucleocytoplasmic Transport Defects in Neurodegenerative Diseases.
    Boehringer A; Bowser R
    Adv Neurobiol; 2018; 20():85-101. PubMed ID: 29916017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired protein degradation in FTLD and related disorders.
    Götzl JK; Lang CM; Haass C; Capell A
    Ageing Res Rev; 2016 Dec; 32():122-139. PubMed ID: 27166223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleocytoplasmic transport in C9orf72-mediated ALS/FTD.
    Zhang K; Grima JC; Rothstein JD; Lloyd TE
    Nucleus; 2016 Apr; 7(2):132-7. PubMed ID: 27116041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress Granule Assembly Disrupts Nucleocytoplasmic Transport.
    Zhang K; Daigle JG; Cunningham KM; Coyne AN; Ruan K; Grima JC; Bowen KE; Wadhwa H; Yang P; Rigo F; Taylor JP; Gitler AD; Rothstein JD; Lloyd TE
    Cell; 2018 May; 173(4):958-971.e17. PubMed ID: 29628143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear Pore Dysfunction in Neurodegeneration.
    Spead O; Zaepfel BL; Rothstein JD
    Neurotherapeutics; 2022 Jul; 19(4):1050-1060. PubMed ID: 36070178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
    Jovičić A; Paul JW; Gitler AD
    J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TDP-43 and FUS en route from the nucleus to the cytoplasm.
    Ederle H; Dormann D
    FEBS Lett; 2017 Jun; 591(11):1489-1507. PubMed ID: 28380257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Nucleocytoplasmic Transport Defects in Amyotrophic Lateral Sclerosis.
    Vanneste J; Van Den Bosch L
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclei Isolation and Super-Resolution Structured Illumination Microscopy for Examining Nucleoporin Alterations in Human Neurodegeneration.
    Coyne AN; Rothstein JD
    J Vis Exp; 2021 Sep; (175):. PubMed ID: 34570098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear pore dysfunction and disease: a complex opportunity.
    Fare CM; Rothstein JD
    Nucleus; 2024 Dec; 15(1):2314297. PubMed ID: 38383349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring and Interpreting Nuclear Transport in Neurodegenerative Disease-The Example of C9orf72 ALS.
    Semmelink MFW; Steen A; Veenhoff LM
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inside out: the role of nucleocytoplasmic transport in ALS and FTLD.
    Boeynaems S; Bogaert E; Van Damme P; Van Den Bosch L
    Acta Neuropathol; 2016 Aug; 132(2):159-173. PubMed ID: 27271576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.